Board of Directors for Macular Degeneration Research, Clinical Trials and Treatment


Brett Cornwell

Brett Cornwell is the Associate Vice Chancellor for Commercialization at The Texas A&M University System. He directs the Office of Technology Commercialization and is responsible for the New Ventures Division which spins out new companies in support of the commercialization of technologies from the Texas A&M University System.

Read More . . .

Philip G. Ralston, Jr.

With more than 35 years in the life science industry as a senior executive, inventor, company founder, venture capitalist and business coach, Phil Ralston has represented companies in public, private and non-profit sectors. He holds 18 patents on various medical products, including drug delivery, monitoring and cardiovascular devices.

Read More . . .

George Chiou, Ph.D.

Dr. George Chiou led the development of Timolol, one of the highest selling ophthalmic pharmaceuticals, and has more than 30 years of ocular pharmacology and therapeutic experience. He is the owner of 30 patents in the research and development of drugs for ocular diseases. Dr.

Read More . . .

Doug Baum

Doug recently joined the board of directors as the Preferred Shareholder representative. He has been involved with MacuCLEAR from the Falll of 2006 as part of the IC2 Institute team that developed MacuCLEAR's prize winning business plan.

Read More . . .